Pharma anti-counterfeiting 2012 by Virtue Insight
"Competences to combat counterfeits in EU and US"
Visit: http://www.virtueinsight.com/pharma/Pharma-Anti-Counterfeiting-2012/
This conference will gather government bodies, pharmaceutical companies and solution and technology providers to discuss the in-depth insights into the strategies and cutting edge technologies for pharmaceutical anti-counterfeiting. For more info write to info.uk@virtueinsight.com
Or Call at +44 2033024659
Key themes discussed at this conference:
• Anti-counterfeiting and product security in EU and USA: government policies and strategies
• Identifying current developments in counterfeits and ways to overcome threats
• Discovering successful business models - opportunities and challenges
• Identify main challenges and methods to improve Global Security
• International partnerships and EU and U.S. regulations to combat counterfeit medicines
• Practical tips - strategies for securing the supply chains of the 21st century - authentication, digital serialization, track and trace technologies and government enforcement
• Best practices on risk based approach to predict and prevent counterfeiting
• Protect your products - Learn how to use the right packaging identification systems effectively
• Discuss the impact of parallel trade and re-imports on counterfeiting medicines
• Effective drug packaging design and technologies enhancing product efficiency, patient and health personnel security, compliance, ease of use
• Establish robust pharmaceutical anti-counterfeiting and brand protection strategy to protect product and brand revenue
• Involve the latest cutting edge serialisation and track and trace technologies for anti-counterfeiting
• Include anti-counterfeiting in your business plan in order to secure product and supply chain safety in your company
• How the FBI is currently addressing intellectual property crime and partnering with U.S. government agencies
Key speakers:
• Ed Wheatley, Regional Investigations Director EMEA, Global Security, AstraZeneca
• Wendy Greenall, Counterfeit Medicines Laboratory Manager - EMEA, Pfizer
• Tomasz Dzitko, CEO, Delfarma
• Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office
• Monika Derecque-Pois, Director General, European Association of Pharmaceutical Full-Line Wholesalers (GIRP)
• Mustafa A. Zaman, Senior Consultant - Integrated Product Development (IPD), Parexel
• Jim Thomson, Chair, European Alliance for Access to Safe Medicines (EAASM)
• Mark Davison, CEO, Blue Sphere Health
• Olgun Yenersoy, CEO, ADVANCO
• Tanvi Goel, Global Serialization Manager, Mylan Pharmaceuticals-(EGA representative)
• Neil Lawrence, AIDC Programme Lead - Department of Health, NHS
• Maarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association)
• Lisa Lovell, Managing Director and Anti-Counterfeiting, Brand Enforcement
• Marietta Ulrich-Horn, General Manager, Securikett
Venue: London